Skip to content
value.today

DBV Technologies S.A.: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

Cash-flow value

Fewer than two of the last three years have both cash from operations and capital spending on file.

Price to bookPrice to book of Biotechnology: $523 M to $2.1 B, median $768 M$0 M$562 M$1.1 B$1.7 B$2.2 B

Your own DCF model

A full discounted-cash-flow model of DBV Technologies S.A., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against the industry Biotechnology

Multiples of its companies with a market value at most 60 days old, times DBV Technologies S.A.'s own figures of FY2025.

Values from the peers' multiples
MultiplePeers (25th / median / 75th)DBV Technologies S.A.Applied toValue (25th to 75th)Companies
Price to book3.1× / 4.5× / 12.3×—book equity $169 M$523 M to $2.1 B70

Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2025to Dec 31, 2025—$-147 M$-120 M———ESEF annual report
FY2024to Dec 31, 2024—$-114 M$-103 M———ESEF annual report
FY2023to Dec 31, 2023——————ESEF annual report
FY2022to Dec 31, 2022——————ESEF annual report

Each figure as filed; the full statements with every line and its filing are on the company page. Market value not on file.

How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.